Advocacy/Lab Management

Thursday, November 7, 2019


12:45pm - 2:00pm


State of Pharmacogenetics

Clinical Implementation of Pharmacogenomics

Philip Empey, PharmD, PhD, University of Pittsburgh, UPMC, Pittsburg, PA, USA

What’s New in Pharmacogenetics?

Victoria M. Pratt. PhD, Indiana University School of Medicine, Indianapolis, IN, USA

Reimbursement: It’s Never too Late to Start Getting Paid

Anthony Sireci, MD, Loxo Oncology, Stamford, CT, USA

Aaron Bossler, MD, PhD, University of Iowa, Iowa City, IA, USA

Demystifying Molecular testing coverage and policies: MolDX and Medicare

Gabriel Bien-Willner. MD, PhD, Palmetto GBA, TX, USA

Biobanking and 3D-Organoid Technology

Perspective on Establishing a Biorepository for Clinical and Research Use

Kristy Crooks, PhD, University of Colorado, Aurora, CO, USA

Profiling the DNA Damage Repair Capacity of High Grade Serous Ovarian Tumors using Patient-Derived Organoids

Sarah Hill, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA

3:45pm - 4:30pm


AMP CPC’s In Silico Reference Materials Working Group: Update & Open Comment Forum

Eric Duncavage, MD, Washington University, Saint Louis, MO, USA

Justin Zook, PhD, National Inst of Standards & Tech, Gaithersburg, MD, USA


Friday, November 8, 2019


10:45am - 12:15pm


Picking a LIMS System

Do-It-Yourself Molecular LIMS

Long P. Le, MD, PhD, Massachusetts General Hospital, Charlestown, MA, USA

Kristina Cusmano-Ozog, MD, Children’s National, Palo Alto, CA, USA

Development of a Laboratory Information System to Support Clinical NGS Testing

Michael Kluk, MD, PhD, Weill Cornell Medicine, New York, NY, USA

Process Validation and Quality Assurance Around the World

ESP Molecular Pathology WG: Diagnosis and Clinical Research Reproducibility

Giorgio Stanta, MD, PhD, University of Trieste, Duino-Aurisina, Italy

Quality Assessment Experience in Brazil

Roberta Sitnik, MSc, PhD, Departamento de Patologia Clínica e Anatomia Patológica, São Paulo, Brazil

1:30pm - 2:45pm


Practical Approaches to Centralizing (or Decentralizing) Molecular Testing

Centralized Testing in Molecular Pathology via Lean Laboratory Design

John Longshore, PhD, Carolinas Pathology Group, Charlotte, NC, USA

Molecular Laboratory Organization: the University of Washington Experience

Daniel E. Sabath, MD, PhD, University of Washington School of Medicine, Seattle, WA, USA

Point Counterpoint: Who Owns Molecular Infectious Disease Testing?

Frederick Nolte, PhD, Medical Univ of South Carolina, Charleston, SC, USA

Nathan Ledeboer, PhD, Medical College of Wisconsin, Milwaukee, WI, USA

New Players in Reimbursement: Laboratory Benefit Managers

(Sponsored by the AMP Economic Affairs Committee)

Panel Discussion

Geoffrey Baird, MD, PhD, University of Washington, Seattle, Washington, USA

Trish Brown, MS, LCGC, Illumina, Inc., San Diego, CA, USA

Heather Agostinelli, Xifin, Inc., San Diego, CA, USA

4:00pm - 5:00pm


Climate Change & Global Surveillance

Arturo Casadevall, MD, PhD, Johns Hopkins, Baltimore, MD, USA



Saturday, November 9, 2019


7:00am - 8:00am


Integrating Genomics into the EHR

Barriers to Integrating Genomics More Fully into the EHR

Brian Shirts, MD, PhD, University of Washington, Seattle, WA, US

1:30pm - 2:45pm


The Future of the AMP v. Myriad Decision: Exploring Potential Impacts on Multigene Panel Testing and Patient Care

(Sponsored by the AMP Professional Relations Committee)

Panel Discussion

Charles Duan, JD, The R Street Institute, Washington, DC, USA
Robert Nussbaum, MD, Invitae, San Francisco, CA, USA
Sandra Park, JD, American Civil Liberties Union, New York, NY, USA
Hans Sauer, JD, Biotechnology Innovation Organization, Washington, DC, USA